Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load

In relapsed acute myeloid leukemia (AML), the only chance for cure is allogeneic stem cell transplantation (allo-SCT) requiring a suitable donor as well as medical fitness of the recipient.[1][1] Although in the majority of transplanted AML patients, the donor immune system engrafts successfully,